Introduction During the period, the Remuneration Committee undertook a comprehensive review of the reward policy for executive Directors.
This remuneration report sets out the Companys policy on the : remuneration of executive and non-executive Directors together with details of Directors remuneration, employment agreements and to create a reward framework that would help drive the next phase of Enodis growth: letters of appointment.
The report was approved by the Board on 19 November 2007 and signed on its behalf by order of the Board.
to ensure that the reward package was strongly aligned to future shareholder value creation: The key developments and decisions taken in the period affecting the executive Directors: to enable Enodis to continue to recruit and retain top management talent in the markets where it operates: and the CEOs contract has been amended reducing the potential payment that he could receive in the event of a change of control: to take account of the feedback the Board had received from shareholders relating to executive Directors contracts and base salaries have been adjusted in order to meet the stated shareholding requirements.
remuneration policy, but still remain at or below the lower quartile of comparable UK Board level salaries: As part of the review, the Committee commissioned a detailed market benchmarking exercise, looking at the three Executive shareholder approval is being sought to increase the level of Director roles.
This exercise considered market levels of performance share awards that may be granted albeit with compensation for comparable companies in both the UK and a more challenging performance condition.
If approved, total remuneration levels will be competitive by reference to both UK US markets.
The three executive Directors were recruited in and US standards: and North America and are based in the US.
share ownership guidelines have been introduced.
In forming its remuneration policy, the Remuneration Committee has given full consideration to the principles set out in Section A of the At the Annual General Meeting of the Company, to be held on Code as defined on page 54.
7 February 2008, an ordinary resolution will be proposed to approve this report.
In addition, there will be an ordinary resolution seeking For non-executive Directors your approval to some changes to the Performance Share Plan The fees for the non-executive Directors are determined by the approved at the 2007 AGM.
Details are included in the Circular to Board.
They are reviewed annually to ensure they are competitive Shareholders which accompanies this Report and Accounts.
and properly reflect the Directors workload and responsibilities at All information disclosed in this Directors remuneration report is that time.
unaudited save where it is stated that the information is audited.
Non-executive Directors do not participate in any of the Groups 2.
Remuneration policy incentive or benefit schemes.
For executive Directors and senior executives Since 2003, the appointment policy for non-executive Directors is that they should be appointed for an initial period of three years.
The policy underlying the remuneration arrangements for executive Copies of the letters of appointment of the non-executive Directors Directors and senior executives is designed to enable the Company are available on request.
There are no provisions for notice periods or to recruit and retain executives of the calibre needed to maintain and compensation in the event of termination of the appointment of the develop Enodis position as one of the worlds leading manufacturers non-executive Directors and no element of their remuneration is and distributors of food equipment.
The policy established by the performance related.
Remuneration Committee is governed by seven principles.
These are that executive remuneration should be: 3.
Remuneration Committee locally competitive, by reference to external markets in the various Composition countries particularly the US where it operates.
In the case of Remuneration policy for executive Directors and the determination Executive Directors, modifications may be necessary to reflect of individual Directors remuneration has been delegated to the UK governance and other requirements: Remuneration Committee.
The Committee consists of Michael seen throughout the business to be fair and equitable: Cronk Chairman, Waldemar Schmidt and Peter Brooks.
Each is a non-executive Director and was a member of the Committee based on total remuneration: throughout the period.
supportive of key strategies: affordable: aligned with shareholder value: and understandable, both internally and externally.
58 | Enodis plc | Directors remuneration report Meetings and function II.
Annual bonus The Committee met seven times during the period, with all Annual cash bonuses are based on Group financial targets.
members present at each meeting.
The Remuneration Committees The measures for executive Directors and senior corporate terms of reference which are available for inspection on the executives for the period were Group operating profit before Companys website include reviewing and setting the remuneration exceptional items and net debt reduction.
If the relevant targets are and benefits packages of the executive Directors.
The Committee met, awards range from 50% threshold, 100% target, to 167% also monitors the level and structure of remuneration for senior maximum of base salary for the Chief Executive and from 42% management, to ensure an appropriate relativity between the threshold, 84% target, to 140% maximum of base salary for the remuneration packages of the executive Directors and senior other executive Directors.
This is no change from previous years.
Hewitt Associates were appointed by the The higher range for the Chief Executive Officer more closely aligns Remuneration Committee as its consultants on 22 May 2003 and his annual bonus plan with the Groups compensation strategy of have since then provided the Remuneration Committee with advice being locally competitive and, being comparable to that of CEOs of and guidance.
They provide no other services and have no other similar sized US businesses.
The Remuneration Committee may add connection with the Group.
The Remuneration Committee is also other corporate or job-related measures as it considers appropriate.
supported by Robert Eimers, the Executive Vice President, Global III.
Long-term incentives: performance share awards Human Resources and David Hooper, the Company Secretary.
Executives have been granted awards under the Performance Share 4.
Policy on outside appointments Plan approved by shareholders at the 2007 Annual General Meeting.
Executive Directors are permitted, with Board approval, to The awards granted to executive Directors in 2007 were over shares hold one non-executive directorship with outside companies.
worth 50% of their pre-review salary.
Such appointment will only be approved where the Board is satisfied Following the remuneration review described earlier in this report, that it will not interfere with the carrying out of the executive it is proposed that the level of participation in the Performance Share Directors role with the Company.
At present, none of the executive Plan by the executive Directors be increased.
This is subject to Directors has any outside appointments.
They may retain any fees shareholder approval at the Annual General Meeting to be held payable to them, with the consent of the Remuneration Committee, on 7 February 2008 and the relevant resolution is included in the except in cases where the directorship is as a representative of circular to shareholders, which accompanies this report.
In the future it is intended that the executive Directors will only 5.
Elements of executive Directors remuneration receive performance share awards rather than a combination of Certain details of Directors contracts, remuneration and interests share options and performance share awards.
In 2008, subject to in the Companys securities, including share options and share shareholder approval to the revised individual grant limit being awards, are set out on pages 61 to 64.
With the implementation obtained at the AGM, it is the Committees intention that the CEO of the new Performance Share Plan in 2007, the Remuneration will be granted a performance share award over shares worth 300% Committee regards the longer term elements of the executive of base salary, the CFO 180% of base salary and the Global EVP Directors remuneration as of primary importance in supporting the 150% of base salary.
These grant levels have been arrived at based Groups remuneration policy and strategy.
on a review of UK and US market practice.
However, as explained in the Circular to Shareholders which accompanies this Report and The remuneration arrangements for the executive Directors Accounts, the performance conditions to be attached to the 2008 consist of: awards will be more challenging.
Base salary Performance conditions Base salaries are not performance-related.
They are determined The performance conditions attached to the 2007 grant of having regard to local competitiveness and to salaries for similar performance share awards were as follows: positions in international businesses of broadly comparable size and structure, taking account of revenue, market value, number a Financial hurdle of employees, business sector and international involvement.
No shares will vest unless the Remuneration Committee is satisfied External consultants are used to provide comparative information that there has been a sustained improvement in the Groups for the Remuneration Committee.
In determining salary increases, underlying financial performance.
the Remuneration Committee is also made aware of salary inflation throughout the Group and takes such information into consideration, together with internal relativities and external survey data.
As a result of the remuneration review described earlier, base salaries were increased with effect from 1 July 2007 to US$850,000 for the Chief Executive Officer, US$430,000 for the Chief Financial Officer and US$325,000 for the Executive Vice President, Global Human Resources.
Directors remuneration report | Enodis plc | 59 Directors remuneration report continued b Total Shareholder Return TSR Options granted to Directors in earlier years have been subject to different performance conditions as follows: There will be no vesting and share awards will lapse unless the TSR performance of Enodis is not less than the TSR of the FTSE options granted under the 1995 Executive Share Option Scheme will be exercisable in normal circumstances only if the increase in Mid-250 index excluding investment trusts over the performance the Groups adjusted earnings per share has exceeded the growth period.
25% of shares will vest if Enodis TSR is in line with the TSR in the Retail Price Index by an average of at least 3% per annum of the FTSE Mid-250 index excluding investment trusts over the over a three year period: performance period, and 100% of shares will vest if Enodis TSR over the performance period is equivalent to the TSR of the FTSE options granted under the 2001 Executive Share Option Scheme Mid-250 index excluding investment trusts plus three percentage in the year ended 29 September 2001 and at 147p in the year points per annum.
Shares will vest on a straight-line sliding scale ended 28 September 2002 will be exercisable in full only if the between these two positions.
Companys TSR is ranked in the upper quartile relative both to other FTSE Mid-250 index companies excluding Investment Process for evaluation of performance conditions Trusts and to a group of about 20 comparable quoted companies.
Options will be exercisable on a sliding-scale basis if the The calculation of whether the performance criteria have been met Companys TSR falls between the median and upper quartile for both options and share awards will initially be prepared for the levels, as compared with the two comparator groups.
In addition, Chairman of the Remuneration Committee, as advised by the no options may be exercised unless the Companys earnings per Companys remuneration consultants.
The figures will be reviewed share growth has exceeded inflation over the relevant and then submitted for the approval of the Remuneration Committee performance period: as advised by its consultants.
Appropriate input from the Audit Committee will be sought, particularly in respect of any EPS options granted under the 2001 Executive Share Option Scheme condition.
This method was selected by the Remuneration at 85.5p in the year ended 28 September 2002 and subsequently Committee as providing shareholders with comfort that all are subject to the same performance conditions as applied to the options granted in the period ended 29 September 2007 and appropriate external advice has been obtained.
Long-term incentives: executive share option schemes performance conditions for options granted under the 2001 Executives hold options under the Enodis 2001 and 1995 Executive Executive Share Option Scheme after December 2005 shall not Share Option Schemes, which use new shares, and the Enodis 1993 be capable of being retested after the end of the first performance Executive Share Option Scheme, which uses shares purchased by an measurement period.
The Remuneration Committee has taken full note of a number of In the period ended 29 September 2007, options have been comments raised on the report last year.
With its consultants, it has granted under the Enodis 2001 Executive Share Option Scheme.
reviewed the performance conditions applicable to future grants The executive Directors were granted share options over shares under the 2001 Executive Share Option Scheme.
It determined that worth 100% of their pre-review base salary.
they remain appropriate for the Group in line with the policy of being locally competitive in remuneration matters.
Therefore, the conditions Performance conditions will remain unaltered for the time being.
The performance conditions attached to the grants in the period are V. Long-term incentives: share matching scheme based on the Companys total shareholder return TSR compared against the companies comprising the FTSE Mid-250 index No awards have been made under the share matching scheme excluding investment trusts at the date of grant, excluding under which executives may be awarded matching free shares companies that have ceased to be listed.
Options granted over linked to the deferral of their annual cash bonus and the shares with a value of up to one times base salary in any financial Remuneration Committee has decided not to operate it.
year will be exercisable in full if Enodis TSR is greater than that of the median ranked company.
Options contained in an award with a value above one times base salary, or in an award which, when aggregated with another award granted in the same financial year, brings the value above one times base salary, will be exercisable as to 35% if Enodis TSR is greater than that of the median ranked company, and exercisable in full if Enodis TSR is at least as great as that of the company ranked at the upper quartile, with pro rata exercisability between these two points.
TSR performance was selected by the Remuneration Committee as the measure, which it considers most closely aligns with shareholder value.
In addition, no options may be exercised unless the Remuneration Committee is satisfied that there has been a sustained improvement in the Groups underlying financial performance.
60 | Enodis plc | Directors remuneration report VI.
Pension As noted in last years Remuneration Report, the Remuneration Committee recognises that there is a balance to be struck between The Company makes payments equivalent to 25% of base salary UK corporate governance where such provisions are not common to the pension arrangements of the executive Directors including practice, and the requirement for the Company to offer a locally contributions to Group pension schemes.
No other element of competitive package given that it is normal for US-based CEOs of remuneration is pensionable.
competitors of the Company to commonly have the benefit of up to VII.
Other benefits not performance-related three years protection and the risk that inadequate protection could influence management responses to any offer for the Company in Executive Directors are provided with medical insurance, disability the future.
insurance, an allowance in lieu of a company car and other benefits in line with practice in other listed companies of similar size.
The Committee has kept this position under review and has now agreed with Mr McCulloch an amendment to the change of 6.
Non-executive Directors remuneration control provision.
Effective 1 July 2007 the provision has been The fees of the Chairman and non-executive Directors were amended so that the 24 months multiplier has reduced to reviewed in November 2007.
It was determined that, whilst their fees 18 months, and effective 1 July 2008, to 12 months.
as non-executive Directors should remain unchanged, the additional The effective dates of the Directors employment agreements were fee of 10,000 p. a. paid to the chairman of the Audit Committee be 1 June 2003 for Mr McCulloch and 21 July 2003 for Messrs Wrench raised to 12,000 p. a. and that a fee of 3,000 p. a. be paid to the and Eimers.
The agreements were amended on 27 June 2007. other members of that Committee, all effective 1 October 2007.
They reflect US employment practice, given that the Directors 7.
Employment agreements and compensation were recruited in North America and are US-based.
The Companys policy with regard to employment agreements for As far as the unexpired terms of employment agreements of executive Directors is that they be rolling contracts and will normally Directors offering themselves for reappointment at the Annual contain a provision entitling the Director to a 12 month notice General Meeting are concerned, Mr Ross has no employment period, or the financial effects thereof, but with the ability to give agreement, his responsibilities being set out in a letter of consideration to a longer period in exceptional circumstances.
Messrs Eimers and Wrench have employment In order to be locally competitive, with regard to termination agreements of an indefinite period terminable at will, as payments under such employment agreements with our US based stated above.
executive Directors, and in order to achieve certainty, liquidated No Director has a material interest in any contract with Group damages have been agreed at their commencement.
companies other than employment agreements.
The employment agreements with each of David McCulloch, David Wrench and Robert Eimers, are for an indefinite period and are terminable at will.
Each agreement contains provisions that, in the event of termination without cause, payment will be made of an amount equivalent to 12 months salary, 12 months target annual bonus, 12 months pension contribution and annual bonus for the current year prorated to date of termination.
In addition, the employment agreement of David McCulloch contained a provision change of control provision, which was in place before his appointment to the Board, whereby if the contract is terminated by a Group company without cause in the event of a change of control or by Mr McCulloch in the event of a change of control, a payment will be made of 24 months base salary, 24 months pension contribution and 24 months target annual bonus.
Directors remuneration report | Enodis plc | 61 Directors remuneration report continued 8.
Directors remuneration and pension information audited Remuneration The remuneration of the Directors for the 52 weeks ended 29 September 2007 is shown below: Base Total Total salary Fees Bonuses Benefits 2007 2006 Director M R Arrowsmith 50,000 50,000 62,000 P M Brooks Chairman 115,000 115,000 151,000 G M Cronk 47,500 47,500 59,500 R C Eimers 142,187 184,573 54,470 381,229 392,192 D S McCulloch 360,482 558,062 112,257 1,030,801 1,062,446 JJRoss 40,000 40,000 52,000 WSchmidt 40,000 40,000 52,000 WDWrench 200,876 260,757 62,881 524,514 559,317 Total 703,545 292,500 1,003,392 229,608 2,229,045 2,390,455 Bonuses paid by reference to achievement by the Group of budgeted financial targets and are calculated by reference to base salary earned in the period.
Bonuses and benefits are not included in pensionable salary.
Includes car allowance and contributions to unapproved defined contribution pension arrangements as detailed in Directors pension information below.
Salaries of North American Directors have been translated at the relevant monthly exchange rate, the average for the year being 1 US$1.98.
No compensation for loss of office or other payments have been paid to or are due for payment to any person who has served as a Director during the financial year.
Pension information The Group paid the following sums to defined contribution pension arrangements for the benefit of the Directors.
These sums are included in the Directors remuneration table above: 2007 2006 Name R C Eimers 24,323 24,775 D S McCulloch 71,205 73,582 WDWrench 30,095 32,303 Total 125,623 130,660 The Group maintains a provision of 1.5m 2006: 1.4m in respect of a pension including tax payable to a former Director.
Directors interests in shares 1 Ordinary shares The beneficial interests of the Directors in office at 29 September 2007 in the ordinary shares of the Company were as follows: 1 October 29 September 2006 Purchases of 2007 ordinary ordinary ordinary Director shares shares shares M R Arrowsmith 50,000 50,000 P M Brooks 86,500 30,000 116,500 G M Cronk 1,791,600 50,000 1,841,600 R C Eimers 15,000 15,000 D S McCulloch 190,000 52,399 242,399 JJRoss 30,000 30,000 WSchmidt 200,000 200,000 WDWrench 10,000 10,000 The above interests are in the ordinary share capital of the Company.
No Director had any beneficial interest in any share capital of other Group companies or in any debenture of any Group company.
As at 19 November 2007 there were no changes to the interests of the Directors in office at the period end as stated above and in the tables on pages 63 and 64.
62 | Enodis plc | Directors remuneration report 2 Share options audited Options to subscribe for or acquire shares of the Company were held during the period by the Directors as disclosed below, each of which was granted for nil consideration.
The aggregate emoluments in the remuneration table on page 62 do not include any amounts for the value of share awards or options to acquire ordinary shares in the Company granted to or held by the Directors.
i The Berisford 1995 Executive Share Option Scheme Executive Scheme 1995 and the Enodis 2001 Executive Share Option Scheme Executive Scheme 2001.
Subject to performance conditions being achieved as described earlier in this report.
When these options are exercised pursuant to the rules of the Scheme, D S McCulloch is entitled to a payment of 404,203.
The employment agreement of Mr McCulloch entered into following his appointment as Chief Executive Officer on 1 June 2003 included a commitment by the Company to grant him share options at the market price prevailing at that time or an alternative benefit payable in cash.
For regulatory reasons the options could not be granted at that time and when they were granted, the market price had risen.
As the rules of the share option scheme require options to be granted at the market price on date of grant, the sum of 404,203 was agreed to be paid.
If these options are not exercised, this sum will not be paid Saved as disclosed, no options lapsed or were exercised during the period and none of the conditions or terms of the options have been varied.
Under the Companies Act, each of the executive Directors is deemed to have an interest in 1,202,652 shares held by the trustee of the Companys employee share trust.
No Director has an actual interest in any of such shares.
During the year the closing prices of the Companys shares have been in the range 173.25p to 224.75p.
On 29 September 2007, the closing mid market share price was 174.5p.
ii The Berisford 1992 Sharesave Scheme Sharesave Scheme 1992.
No Director holds options under the Sharesave Scheme 1992.
Directors remuneration report | Enodis plc | 63 Directors remuneration report continued 3 Performance shares audited The Enodis Performance Share Plan Number of shares awarded during the period At At Date 1 October 29 September Date from which Director 2006 Granted 2007 of grant shares vest R C Eimers 33,383 33,383 06.06.07 06.06.10 D S McCulloch 83,458 83,458 06.06.07 06.06.10 WDWrench 48,381 48,381 06.06.07 06.06.10 Subject to performance conditions being achieved as described earlier in this report.
Share ownership guidelines The Company is a member of the FTSE Mid-250 index and has been for some time, including when its current executive share option The Remuneration Committee is aware of its responsibility to ensure scheme was adopted.
The FTSE Mid-250 index excluding that the interests of executive Directors are seen to be aligned investment trusts was therefore selected as the comparator group with those of shareholders.
Accordingly, during the year, it has for measuring performance conditions in the Companys executive introduced share ownership guidelines under which executive share option scheme.
Accordingly, the Remuneration Committee Directors are required to acquire and maintain a shareholding of considers that to be the most appropriate broad market index for Enodis shares worth at least one times base salary.
For this purpose, identifying the Companys relative performance for the purpose of vested share awards and share options that have satisfied all this report.
performance conditions but have not been exercised will count towards the guidelines net of tax.
Directors are expected to comply In order to provide a more recent relative performance review, set with the guidelines within five years of their appointment to the out below is a chart showing relative Company TSR for each of the Board or 1 October 2012 or later.
If the Director does not meet the last three years.
target by that time, he is expected to retain at least 50% of shares Enodis plc FTSE Mid-250 index acquired on the vesting of share awards or exercise of share options after selling sufficient shares to meet the strike price if any and the 225 tax liability.
200 Compliance by each Director with the guidelines for FY07 is set 175 out below: 150 Shares 125 Shares and Name Target vested options 100 R C Eimers 85,835 412,347 75 D S McCulloch 224,216 1,312,000 Sep 2004 Sep 2005 Sep 2006 Sep 2007 W D Wrench 113,564 604,419 This graph shows the value, by 30 September 2007, of 100 invested in Enodis on 2 October 2004 compared with the value of 100 invested in the FTSE Mid-250 index.
The other points plotted are the values at intervening financial year-ends.
Performance graph Total Shareholder Return TSR Source: Datastream Set out below is a graph showing the Companys TSR for each of the last five years compared to the companies comprising the Approved by order of the Board FTSE Mid-250 index.
The TSR was calculated using a fair method in accordance with the Companies Act 1985, Schedule 7A pt2 paragraphs 4 4 to 8.
Enodis plc FTSE Mid-250 index D R Hooper Secretary 400 19 November 2007 350 300 250 200 150 100 50 Sep 2002 Sep 2003 Sep 2004 Sep 2005 Sep 2006 Sep 2007 This graph shows the value, by 30 September 2007, of 100 invested in Enodis on 28 September 2002 compared with the value of 100 invested in the FTSE Mid-250 index.
Source: Datastream 64 | Enodis plc | Directors remuneration report
